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In ahumanMLC, highly purified peripheral bloodT cells proliferate in response
to allogeneic peripheral blood stimulator cells (1). This implies that human alloan-
tigens can be recognized "directly" on the allogeneic stimulator cells, i.e ., without
participation of autologous antigenpresenting/processing cells(APC)(2-5) . In con-
trast, in the xenogeneic model of a human anti-mouse MLC, purified human re-
sponderT cells are unable to proliferate to murine spleen cells ; apparently human
T cells do not respond to the mouse xenoantigens "directly" on the murine stimu-
lator cells. When humanAPC are present in the xenogenicMLC (6, 7), a response
does take place that is presumed to bean "indirect" response in which thexenogeneic
antigens are presented as peptides on the responder (self) APC.
There are several possible explanations for the failure to find a "direct" human
anti-mouse response, including (a) a failure ofhuman accessory molecules (CD4,
CD8, LFA1, CD2) to find theirappropriate ligands on murine cells (8) ; (b) the failure
ofthe humanT cell repertoire to include direct recognition of xenogeneic antigens,
presumably based on the fact that the humanT cells educated in a human thymus
are not selected to recognize a molecule as disparate as mouse H-2 antigens, or (c)
that humanT cells can recognize xenoantigen directly but that requisite cytokines
produced by murine APCs, e.g . IL-1, are not available in a form and/or amount
adequate to promote proliferation in human T cells .
We report here the finding that highly purified humanTcells can respond directly
andin an antigen-specific manner tomurine xenoantigens in the presence ofhuman
recombinant IL-1, IL-2, oraT cell growth factor (TCGF) preparation.These findings
demonstrate that the humanT cell repertoire does include the ability to recognize
very widely disparate, i.e ., murine, xenoantigens and that direct recognition canbe
obtained provided human cytokines are included in the cell reaction mixture .
Materials and Methods
BriefDefinitive Report
Cell Isolation-responding Cells.
￿
Human responding cells are either PBMC from the inter-
face of aFicoll-Hypaque gradient or highly purifiedT cells from peripheral blood . To obtain
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purified Tcells, PBMC are incubated on nylon wool columns in 10% human serum RPMI
1640 with 25 mM Hepes and antibiotics and r.-glutamine, i.e., complete tissue culturemedia
(TCM). After 60 min at 37°C, nonadherent cells are eluted and depleted of adherent cells
by incubation in 100-mm petri dishes (No. 1029; Falcon Labware, Oxnard, CA) overnight
at 37°C in 5% C02 and air. Any residual nonT cells are removed from the petri dish nonad-
herent fraction by antibody plus complement depletion as previously described (9), using
anti-human HLA-DR (No. 7360; cloneL243; Becton Dickinson [B-D] Mountain View, CA),
anti-human Leu-7(B-D No. 7390, clone HNK-1), anti-human Leu-11b(B-D No. 7530, clone
G022), anti-Mo2 (No. 660214; Coulter Immunology, Hialeah, FL), andanti-NKH-IA (No.
6603420;CoulterImmunology). Cellsareincubated with theseantibodies at 4°C for45 min,
centrifuged, and the cell pellet resuspended in Lympho-Kwik T (One Lambda, Inc., Los
Angeles, CA) and incubated at 37°C for 30 min. After washing, these cells are referred to
as purified T cells.
Stimulating Cells.
￿
Murine stimulating cellsarespleen cells (depleted of RBC) from BALB/c,
B10.BR, (Jackson Laboratories, Bar Harbor, ME) and B10.Q(from Dr. Chella David, Mayo
Clinic, Rochester, MN). The cells are irradiated with 2,500 rad. Human stimulating cells
are PBMC irradiated with 4,000 rad.
Cell Cultures.
￿
MLCs are composed of responding cells (105/well) mixed with murine
stimulating cells (8-10 x 105/well). Human autologous PBMC, used as a source of recon-
stitutingaccessorycells or APC, are irradiated (4,000 rad) and used at 105/well. Human al-
logeneic, irradiated stimulating PBMC are used at 3 x 105 cells/well. Cultures are incubated
in 5% C02 at 37°C in 200,ul TCM in 96-well, flat-bottomed Linbro plates (No. 76-032-
05; Flow Laboratories, MacLean, VA) for 5 d and labeled with 1 ttCi [3H]TdR (6.7 Ci/mM)
during thefinal 7 h of culture. Data are expressed as mean counts perminute (cpm) t stan-
dard deviation (SD) of triplicate cultures.
Primed Lymphocyte Typing (PLT).
￿
ForPITcultures (6, 10), 107 human responding T cells
or PBMC (as indicated) are cultured together with 1.9 x 107 BALB/cx spleen cells in the
presence ofirradiated reconstituting autologous human PBMC at 107 per flask or cytokines
(rIL-1, rIL-2, TCGF concentrations given in the text) in 20 ml TCM in upright 25-cm2
Corning flasks (No. 25100; Corning, NY). After 3 d of culture, 10 ml fresh TCM is added
and every 2-3 d thereafter 8 ml of medium is removed from each flask and 8 ml fresh TCM
is added. After 10-11 dof culture, thecells are restimulated in PITin TCM in flat-bottomed
96-well Linbro plates at 105 primed responding cells per well with 106 irradiated murine
stimulating cells or 2 x 105 irradiated allogeneic human PBMC. Cultures are terminated
2, 3, or 4 d later. Cells are labeled with [3H]TdR during the last 7 h of culture and data
are expressed as noted above.
Cytokines.
￿
rIL-1/3 (Genzyme, Boston,MA)and rIL-2, agift from CetusCorp., (Emeryville,
CA)are givenin units permilliliter. TCGF is givenas percentof final totalvolume in culture
(Catalog No. 812810, LymphocultT ; BioTest, Frankfurt, Federal Republic ofGermany). OKT3
(Ortho Diagnostic Systems, Westwood, MA) is used at 50 ng/mlfinal concentration. PHA-P
(No. L-9132, Sigma Chemical Co., St. Louis, MO) is used at 1% vol/vol final concentration
in cultures.
Results and Discussion
Purified T cells used in these studies were assessed for functional purity by their
inability to respond to OKT3 and a markedly reduced response to PHA (Table I).
That theTcellswere functionally intact was verified by their response to these stimuli
if irradiated, autologous PBMC, as a source of APC, were present in the culture
system (i .e., a "reconstituted response"). This "reconstituted" response to PHA or
OKT3 was, in all cases, comparable to that of unseparated PBMC (Table I).
Resultsshownin Table II from three separate experiments confirm earlier findings
that purified human T cells do not respond proliferatively to mouse xenoantigens
(6, 7). Addition of autologous human PBMC (x-irradiated) as a source of APC toALTER AND BACH
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TABLE I
Lack of Response of Highly Purified T Cells to Polydonal Stimulation
Responder
cell
￿
Stimulus
￿
Exp. 1003
￿
Exp. 1005
￿
Exp. 1006
the human T cell-mouse spleen cell mixture reconstitutes a strong proliferative re-
sponse to the BALB/c xenoantigens. This T cell response is always greater, in terms
of cpm incorporated, than the response of human PBMC to murine stimulating
cells(data not shown). In contrast, human T cells cultured in MLC with allogeneic
irradiated PBMC respond proliferatively, as has been shown previously (1), and do
not require additional "reconstituting" cells.
To understandthe mechanism(s) whereby irradiated autologous PBMC reconsti-
tute a T cell xenogeneic response, we used human cytokines to substitute for the
human PBMC/APC . Data in Table II show that addition of rIL-1, rIL-2, or TCGF
to the purified T cells allows a significant proliferative response to murine stimulating
cells. As shown, the purified T cells in the absence of BALB/c stimulating cells do
not respond to rIL-1; the response to rIL-2 or TCGF alone is very weak compared
with the response in the presence of both the cytokine and the BALB/c cells.
We then used a PIT approach (10) to evaluate the immunogenetic specificity of
the human T cell proliferative response to BALB/c xenoantigens. Purified human
T cells were cultured with BALB/c-irradiated splenic stimulating cells in the ab-
sence or presence of autologous, irradiated PBMC or rIL-1 or rIL-2 or TCGF. After
10 d of culture, the primed responding cells were restimulated with irradiated cells
from several sources. Results are shown in Table III. T cells primed to BALB/c in
the presence of APBMCx or rIL-1, or rIL-2, or TCGF show a highly significant
secondary proliferative response to BALB/c restimulating cells as is expected if the
primary proliferative response was specifically to BALB/c antigens; there is no prolifer-
ative response to stimulating cells ofother mouse strains, B10.% or B10.BRx. These
results demonstrate that cells proliferating in the primary human anti-mouse MLC
in the presence of rIL-1, rIL-2, or TCGF respond in an antigen-specific manner.
The relatively low level proliferation seen on day 2 in response to allogeneic human
cells (BPBMCx) in the PIT probably reflects the onset of a primary allogeneic re-
sponse of unprimed T cells present in the responding population. We cannot rule
out shared specificities between mouse and human stimulating antigens that may
also contribute to the allogeneic proliferative response.
The lack of any response to the third-party murine stimulator cells in the PIT
ApBMc TCM
PHA
OKT3
63 ± 8'
144,791 ± 4,232
82,446 t 10,625
mean cpm
174 t
312,771 t
164,331 t
± SD
124
6,720
20,990
165
443,677
205,587
t 24
t 6,366
t 11,858
AT TCM 29±10 49±3 52±12
PHA 488 ± 106 2,017 ± 210 4,648 ± 364
OKT3 72 ± 25 68 ± 25 59 ± 12
AT TCM + Apamcx NT NT 69 ± 17
PHA + APBMCx NT 249,369 ± 10,883 403,306 ± 26,920
OKT3 + ApBmc. NT 150,264 ± 12,995 138,297 ± 12,688336
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TABLE II
Primary MLC Response of Purified Human T Cells to Murine Xenoantigen
` Exp. 1003 : rIL-1, 10 U/ml ; rIL-2, 10 A/ml ; TCGF, 10% .
: Exp. 1005: rIL-1, 10 U/ml ; rIL-2, 40 u/ml ; TCGF, 10% .
5 Exp . 1006: rIL-1, 9 U/ml ; rIL-2, 200 u/ml ; TCGF, 10% .
Purified T cells of a different individual were used as responding cells in each experiment .
TABLE III
PLT Response of Human T Cells Primed to Murine Xenoantigen
ApBMCx ApBMCx
BPBMCx
BALB/c.
B10.Q,
1310.BRx
195 t 46
1,166 t 352
4,090 t 1,324
1,362 t 819
1,547 t 745
93 t 26
2,565 t 799
11,695 t 5,538
1,626 t 780
1,841 f 1,302
93 t
13,377 t
3,275 t
2,016 t
961 t
33
9,855
1,938
372
477
AT + BALB/c. + TCM 154 ± 44 30 ± 2 50 1 9
rIL-1 (10 U/ml) ApBMCx 463 t 443 98 t 4 115 t 21
BPBMCx 8,141 t 6,897 13,215 t 2,623 52,266 t 5,473
BALB/cx 62,055 t 5,587 96,159 t 11,000 23,942 t 2,559
BMQ 881 t 258 456 t 46 972 t 88
B10.BRx 631 t 405 393 f 199 207 t 103
AT + BALB/cx + TCM 215 t 58 62 ± 26 54 t 14
rIL-2 (10 U/ml) ApBMCx 390 t 70 189 t 97 161 ± 3
BPBMCx 8,747 t 2,149 20,330 t 4,993 63,257 ± 8,005
BALB/c. 29,632 t 1,838 5,072 t 733 737 t 212
B10 ., 1,278 t 562 265 t 95 735 t 144
B10.BRx 1,772 t 1,514 276 f 234 166 t 102
AT + BALB/c. + TCM 137 ± 45 31 ± 2 62 ± 9
TCGF (10%) ApBMCx 280 t 145 177 t 134 136 t 63
BPBMCx 9,701 t 2,222 33,065 t 4,871 91,774 t 8,629
BALB/c . 39,850 t 898 111,781 t 12,610 72,412 ± 11,120
B10.Q, 1,904 t 942 2,822 t 827 1,986 t 477
B10.BRx 513 t 94 555 t 483 499 t 395
Primary stimulation
day 0
Restimulus
day 10 Day
Proliferation following restimulation
2 Day 3 Day 4
AT + BALB/c . + TCM TCM 129 t 37 NT NT
ApBMCx 149 t 12 77 t 20 NT
BPBMCx 522 t 145 3,453 t 680 NT
BALB/c. 219 t 135 221 t 118 NT
B10 ., 190 ± 166 198 t 58 NT
BMBR x 97 t 14 50 t 8 NT
AT + BALB/c. + TCM 154 t 25 76 t 57 62 ± 15
Exp .
Added
stimulus TCM ApBMCx rIL-1
mean
HL-2
tpm t SD
TCGF BPBMCx
1003` TCM 62 t 3 224 t 220 56 f 12 699 t 208 4,737 f 1,018 16,703 t 4,943
BALB/c x 102 t 28 15,678 t 15,628 5,236 t 3,361 11,516 t 2,319 35,430 t 8,738 NT
1005: TCM 184 t 203 47 t 22 47 f 8 3,074 t 323 1,880 t 240 115,430 t 9,348
BALB/c x 510 t 319 36,322 t 14,003 4,963 t 1,349 23,098 t 1,545 40,920 t 3,604 NT
10065 TCM 55 t 7 46 t 7 192 t 298 2,449 t 63 2,008 t 127 106,426 t 6,083
BALB/c x 336 t 358 25,013 t 8,770 10,197 t 1,929 34,794 t 10,214 40,709 t 3,164 NTALTER AND BACH
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compared with thepositive allogeneic response may be basedon the need, as demon-
stratedin theprimary response, forhumancytokinesto permit a human anti-mouse
response. These data, in aggregate, suggest that the cytokine requirements differ
for the primary and secondary xenogeneic responses.
It was clear from earlier results that human T cells can respond to murine an-
tigens in the presence of human APC. Such a response could be based solely on
recognition ofmurine peptides presented by those self-APC. Thepresentresults dem-
onstrate that an antigen-specific human anti-mouse response based on direct recog-
nition of the murine antigens in the presence of human cytokines does occur, i.e.,
that the human T cell repertoire includes receptors that permit direct recognition
of murine antigens.
While thedata shown here address the issue ofthehuman T cell repertoire vis-a-
vis recognition of highly disparate xenogeneic antigens, they do not provide direct
information regardingtheextent to whichthat repertoire may be quantitatively limited
compared with the repertoire that recognizes alloantigens. The data also do not ad-
dress the issue of the ability ofhuman CD4 and CD8 molecules or of other human
cell surface molecules to interact significantly with the murine homologues oftheir
human ligands.
Ourinitial hypothesis forthis studywas that there is no response ofpurified human
Tcellsto murine xenoantigens becausethereis aneed foran APC-produced cytokine,
such as IL-1, to allow the response to take place, and the murine IL-1 would not
provide an adequate stimulus to the human cells under these conditions (6). Our
finding that the addition of human rIL-1 to these cultures allowed a response sug-
gests that this may be a reasonable explanation.
In the past we have presented evidence that the proliferative response in human
anti-mouse MLC (in which both responder and stimulator APC were present) was
very largely directed against class II antigens of H-2 (6). In that system, however,
it was not clear whether the class II antigens were being recognized directly or in-
directly; it is at least possible that the majority, or all, of that response was an in-
direct response in which murine class II peptides were presented on human, autolo-
gous APC. In the present studies, there is, by definition, direct recognition of the
murine xenoantigens. Experiments are currentlyin progress to evaluate whichclass(es)
ofantigens are recognized and which subpopulations ofhumanTcells areresponding
under these conditions.
Based on studies of alloantigen recognition, we proposed that stimulation of
precursorT cellswith alloantigen alone(signal 1 to theT cell) drove thosecells along
the pathway of maturation to become "poised" to receive help in the form of what
is now recognized to be IL-2 by upregulating receptors forIL-2 (11). We would sug-
gest from the data reported herein that direct recognition by human T cells of mu-
rine xenoantigens does occur, and results in the delivery of a signal I to the human
T cells that then renders the T cells responsive to subsequent addition of rIL-1 (12)
or rIL-2.
Summary
Purified human T cells respond proliferatively to allogeneic peripheral blood
mononuclear (PBMC) stimulating cells but show no response to murine splenic
stimulating cells. Two possible explanations for the lack of xenogeneic response are338
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that human T cells, educated in a human thymus, cannot directly recognize a mole-
cule as disparate as mouse antigen encoded by H-2 and/or that a cytol.ine(s) pro-
duced by the APCs is needed to allowa proliferative response and that the cytokine(s)
produced by murine APC do not provide an adequate stimulus to the human T
cells under these conditions. We show here that highly purified human T cells can
respond directly in an antigen-specific manner to murine stimulating cells ifhuman
rIL-1 or rIL-2 or a T cell growth factor (TCGF) preparation are present in the cul-
ture. These findings demonstrate that human T cellscan recognize murine antigens
and that a highly significant response can be obtained ifa human cytokine is present
to permit that response.
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